Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Sarcoma and Rare Cancers Congress 2025

Added value brought by artificial intelligence (AI) in rare cancers

AI for novel targets in uveal melanoma

Date

22 Mar 2025

Session

Added value brought by artificial intelligence (AI) in rare cancers

Topics

Rare Cancers

Tumour Site

Presenters

Bissan Al-Lazikani

Authors

B. Al-Lazikani

Author affiliations

  • Genomic Medicine Dept., The University of Texas MD Anderson Cancer Center, 77030 - Houston/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Added value brought by artificial intelligence (AI) in rare cancers

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.